Switch to:
AbbVie Inc (NYSE:ABBV)
Accounts Payable
$6,954 Mil (As of Dec. 2014)

AbbVie Inc's quarterly accounts payable increased from Jun. 2014 ($6,046 Mil) to Sep. 2014 ($6,312 Mil) and increased from Sep. 2014 ($6,312 Mil) to Dec. 2014 ($6,954 Mil).

AbbVie Inc's annual accounts payable increased from Dec. 2012 ($4,016 Mil) to Dec. 2013 ($6,448 Mil) and increased from Dec. 2013 ($6,448 Mil) to Dec. 2014 ($6,954 Mil).


Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

AbbVie Inc Annual Data

Accts Payable 000003,7614,7154,0166,4486,954

AbbVie Inc Quarterly Data

Accts Payable 5,3684,0166,3306,3736,4416,4486,1966,0466,3126,954
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial